Filing Details

Accession Number:
0001161697-24-000256
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 17:00:08
Reporting Period:
2024-06-05
Accepted Time:
2024-06-07 17:00:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279473 Gary Ingenito 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Chief Med. & Reg. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2024-06-05 80,000 $4.01 131,391 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2024-06-05 80,000 $16.16 51,391 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2024-06-05 80,000 $0.00 80,000 $4.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,050,575 2025-01-02 No 4 M Direct
Footnotes
  1. Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share.
  3. Options vested in three annual tranches beginning on January 2, 2019.